Boston Scientific has shown high revenue and EPS growth rates in recent years. See why I recommend a hold rating for BSX stock.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Boston Metal, a supplier of steel decarbonization technology, has successfully commissioned its multi-inert anode Molten ...

Digital voice recordings contain valuable information that can indicate an individual’s cognitive health, offering a non-invasive and efficient method for assessment. Research has demonstrated that ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.

Today's Research Daily features new research reports on 16 major stocks, including The Goldman Sachs Group, Inc. (GS), The Progressive Corp. (PGR) and Boston Scientific Corp. (BSX), as well as ...

The United States has historically made substantial scientific and monetary contributions to the IPCC. US scientists publish research that informs the assessment and run computer simulations of ...

TUESDAY, Feb. 25, 2025 (HealthDay News) -- Boston Scientific has issued a recall of Accolade pacemaker devices, according to a safety communication from the U.S. Food and Drug Administration. The ...

TUESDAY, Feb. 25, 2025 (HealthDay News) -- Boston Scientific has issued a recall of Accolade pacemaker devices, according to a safety communication from the U.S. Food and Drug Administration.

The FDA is further elevating a pacemaker recall from Boston Scientific that it first broadcast in December over certain Accolade implants that can place themselves into a permanent safety mode and ...

--Worst four day stretch since the four days ending June 14, 2022, when it fell 9.9% --Down 4.75% month-to-date; on pace for worst month since June 2022, when it fell 9.12% --Up 9.15% year-to-date ...